Clene (CLNN) 10% holder’s LLC sells 4,278 shares, keeps 426,816

Rhea-AI Filing Summary

Clene Inc. ten percent owner associated entity sells shares. An entity linked to Ugwumba Chidozie, SymBiosis II, LLC, completed an open-market sale of 4,278 shares of Clene Inc. common stock at $4.97 per share. After this transaction, the entity still holds 426,816 shares indirectly.

Insider Trade Summary

Net Seller: 4,278 shares ($21,262)

Net Sell 1 txn

Insider Ugwumba Chidozie

Role 10% Owner

Sold 4,278 shs ($21K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,278	$4.97	$21K

Holdings After Transaction: Common Stock — 426,816 shares (Indirect, By SymBiosis II, LLC)

Footnotes (1)

Key Figures

Shares sold: 4,278 shares Sale price: $4.97 per share Shares owned after: 426,816 shares

3 metrics

Shares sold 4,278 shares Open-market sale of common stock

Sale price $4.97 per share Price for sold common stock

Shares owned after 426,816 shares Indirect holdings by SymBiosis II, LLC after sale

Key Terms

open-market sale, indirect ownership, ten percent owner

3 terms

open-market sale financial

"transaction_action: "open-market sale" for the common stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

indirect ownership financial

"direct_or_indirect: "I" and nature_of_ownership: "By SymBiosis II, LLC""

ten percent owner financial

"is_ten_percent_owner: 1 for reporting person Ugwumba Chidozie"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ugwumba Chidozie

(Last) (First) (Middle)

609 SW 8TH STREET

SUITE 510

(Street)

BENTONVILLE ARKANSAS 72712

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		S		4,278	D	$4.97	426,816	I	By SymBiosis II, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Chidozie Ugwumba	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Clene (CLNN) report in this Form 4?

Clene reported an open-market sale of 4,278 common shares by SymBiosis II, LLC, an entity associated with ten percent owner Ugwumba Chidozie, at $4.97 per share, leaving 426,816 shares owned indirectly afterward.

Who executed the recent share sale reported for Clene (CLNN)?

The sale was executed by SymBiosis II, LLC, noted as indirect ownership for ten percent owner Ugwumba Chidozie. This means the transaction is attributed to the LLC rather than a direct personal sale by Chidozie himself.

How many Clene (CLNN) shares were sold and at what price?

SymBiosis II, LLC sold 4,278 shares of Clene common stock in an open-market transaction at a price of $4.97 per share, according to the reported Form 4 insider trading data.

How many Clene (CLNN) shares remain held after this insider sale?

Following the transaction, SymBiosis II, LLC is reported to indirectly own 426,816 shares of Clene common stock. This figure reflects the total holdings after the 4,278 shares were sold in the open-market trade.

Is the Clene (CLNN) insider sale a direct or indirect holding change?

The reported transaction involves a change in indirect ownership. Shares are held "By SymBiosis II, LLC," so the Form 4 attributes the sale to that entity, with Ugwumba Chidozie listed as the reporting ten percent owner.